Richard Brand is Chief Financial Officer of Laboratory for Advanced Medicine.
Previously, Mr. Brand served as the Chief Financial Officer of BeyondSpring (NASDAQ: BYSI). He was Chairman and Chief Executive Officer of Point Capital, a consultant of the Whalehaven Group of Funds and a registered representative with Andrews Securities where his responsibilities included acting as dealer manager for Keating Capital. Mr. Brand also served as Managing Director of Caisse des Dépôts Securities and FleetBoston Robertson Stephens.
Mr. Brand was Head of Origination and Managing director of Prospect Capital Management and an Investment Advisor and Personnel of Prospect Energy Corp. At Prospect, he focused on sourcing and screening potential Prospect Energy investments. Mr. Brand was with Prospect Capital Management since October 2004.
Mr. Brand began his career as an Investment Banker at PaineWebber in 1980. As a banker and private equity professional, he structured debt financings for a number of oil and gas companies. He served as the Managing Director of Robertson Stephens, where he served on Bayview Fund, the partners’ investment fund and was a Council Member at Gerson Lehrman Group and Advisory Council Member at Global Capital Service Group. He served as Vice President of Donaldson, Lufkin & Jenrette, where he helped establish the Private Funds Group.
Mr. Brand is a member of the Global Association of Risk Professionals. He is the Series 7 – General Securities Representative and the Series 63 – Uniform Securities Agent State Law Examination Securities Representative. He received his MBA in Finance from University of Chicago and his BA in Economics and English from University of Iowa (Phi Beta Kappa).
Listen to the interview with Richard (published July 2019) . https://mendelspod.com/podcasts/early-cancer-detection-company-ahead-grail/